A mouse model for poliovirus neurovirulence identifies mutations that attenuate the virus for humans
- PMID: 3039178
- PMCID: PMC255821
- DOI: 10.1128/JVI.61.9.2917-2920.1987
A mouse model for poliovirus neurovirulence identifies mutations that attenuate the virus for humans
Abstract
A mutation in the genome of poliovirus type 3 that is known to reduce neurovirulence in humans similarly reduces neurovirulence in mice when incorporated into a mouse-adapted-human poliovirus recombinant. Viral recombinants with a uracil at nucleotide position 472 in the 5'-noncoding regions of their genomes are unable to replicate in the mouse brain. Viral recombinants with a cytosine at this position are neurovirulent in mice. Neurovirulence of poliovirus in mice may therefore prove to be a useful indicator of the genetic stability of new attenuating mutations created by site-directed mutagenesis.
Similar articles
-
Identification of two determinants that attenuate vaccine-related type 2 poliovirus.J Virol. 1991 Mar;65(3):1377-82. doi: 10.1128/JVI.65.3.1377-1382.1991. J Virol. 1991. PMID: 1847458 Free PMC article.
-
Translation deficiency of the Sabin type 3 poliovirus genome: association with an attenuating mutation C472----U.Virology. 1990 Mar;175(1):103-9. doi: 10.1016/0042-6822(90)90190-3. Virology. 1990. PMID: 2155504
-
Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype.Virology. 1999 May 25;258(1):152-60. doi: 10.1006/viro.1999.9718. Virology. 1999. PMID: 10329577
-
[Genetic determinants of neurovirulence and attenuation of poliovirus].Mol Gen Mikrobiol Virusol. 1988 Jan;(1):3-9. Mol Gen Mikrobiol Virusol. 1988. PMID: 2833691 Review. Russian.
-
[Molecular genetic analysis of poliovirus infection].Yakugaku Zasshi. 1989 Sep;109(9):622-35. doi: 10.1248/yakushi1947.109.9_622. Yakugaku Zasshi. 1989. PMID: 2481725 Review. Japanese.
Cited by
-
Determination of the structure of a decay accelerating factor-binding clinical isolate of echovirus 11 allows mapping of mutants with altered receptor requirements for infection.J Virol. 2002 Aug;76(15):7694-704. doi: 10.1128/jvi.76.15.7694-7704.2002. J Virol. 2002. PMID: 12097583 Free PMC article.
-
Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine.J Virol. 1989 Mar;63(3):1338-44. doi: 10.1128/JVI.63.3.1338-1344.1989. J Virol. 1989. PMID: 2536836 Free PMC article.
-
Genomic analysis of recombinant sabin clinical isolates.Virus Genes. 2006 Apr;32(2):203-10. doi: 10.1007/s11262-005-6877-1. Virus Genes. 2006. PMID: 16604453
-
Genomic regions of neurovirulence and attenuation in Theiler murine encephalomyelitis virus.Proc Natl Acad Sci U S A. 1990 Feb;87(3):978-82. doi: 10.1073/pnas.87.3.978. Proc Natl Acad Sci U S A. 1990. PMID: 2153981 Free PMC article.
-
Substitutions in the capsids of poliovirus mutants selected in human neuroblastoma cells confer on the Mahoney type 1 strain a phenotype neurovirulent in mice.J Virol. 1994 Dec;68(12):8386-91. doi: 10.1128/JVI.68.12.8386-8391.1994. J Virol. 1994. PMID: 7966631 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources